These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 27824286

  • 1. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
    Li Z, Zeng H, Wang Y, Zhang Y, Cheng L, Zhang F, Lei Y, Jin B, Ma Y, Chen L.
    Hum Vaccin Immunother; 2017 Apr 03; 13(4):802-807. PubMed ID: 27824286
    [Abstract] [Full Text] [Related]

  • 2. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW, Moon JE, Paolino KM, Newcomer R, McLain DE, Josleyn M, Hannaman D, Schmaljohn C.
    Clin Microbiol Infect; 2014 May 03; 20 Suppl 5():110-7. PubMed ID: 24447183
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Long term epidemiological effects of vaccination on hemorrhagical fever with renal syndrome (HFRS) in Shaanxi provincial HFRS epidemic areas].
    Wang JJ, Wei ZZ, Wei J, Ma CA, Dong JH, Lu XL, Zheng Y, Yu PB, Qu JH, Dong LF.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar 03; 33(3):309-12. PubMed ID: 22613385
    [Abstract] [Full Text] [Related]

  • 5. [Serological surveillance on vaccine against hemorrhagic fever with renal syndrome].
    Gong ZY, Weng JQ, Zhao ZY, Chen YT, Zhu AG, Fu GM, Fang CF, Zhu ZY, Chen EF, Wang CZ, Wang W, Lei LH, Wang Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May 03; 25(5):400-2. PubMed ID: 15231163
    [Abstract] [Full Text] [Related]

  • 6. Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.
    Ying Q, Ma T, Cheng L, Zhang X, Truax AD, Ma R, Liu Z, Lei Y, Zhang L, Ye W, Zhang F, Xu Z, Shang L, Liu R, Wang F, Wu X.
    Oncotarget; 2016 Sep 27; 7(39):63488-63503. PubMed ID: 27542281
    [Abstract] [Full Text] [Related]

  • 7. Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination.
    Woo GJ, Chun EY, Kim KH, Kim W.
    J Microbiol; 2005 Dec 27; 43(6):537-45. PubMed ID: 16410771
    [Abstract] [Full Text] [Related]

  • 8. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper JW.
    Vaccine; 2012 Mar 02; 30(11):1951-8. PubMed ID: 22248821
    [Abstract] [Full Text] [Related]

  • 9. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization.
    Xu Z, Wei L, Wang L, Wang H, Jiang S.
    Biochem Biophys Res Commun; 2002 Nov 08; 298(4):552-8. PubMed ID: 12408987
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y, Liu W, Xu X, Weng SQ, Shao SK, Zhou WQ, Teng Z, Gu HX, Zhu ZY, Xu ZY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep 08; 15(3):274-6. PubMed ID: 11986705
    [Abstract] [Full Text] [Related]

  • 11. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
    Dong Y, Ma T, Zhang X, Ying Q, Han M, Zhang M, Yang R, Li Y, Wang F, Liu R, Wu X.
    J Med Microbiol; 2019 Mar 08; 68(3):480-492. PubMed ID: 30657443
    [Abstract] [Full Text] [Related]

  • 12. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW, Josleyn M, Ballantyne J, Brocato R.
    Vaccine; 2013 Sep 13; 31(40):4314-21. PubMed ID: 23892100
    [Abstract] [Full Text] [Related]

  • 13. Specific humoral reaction of hemorrhagic fever with renal syndrome (HFRS) patients in China to recombinant nucleocapsid proteins from European hantaviruses.
    Xiong HR, Li Q, Chen W, Liu DY, Ling JX, Liu J, Liu YJ, Zhang Y, Yang ZQ.
    Eur J Clin Microbiol Infect Dis; 2011 May 13; 30(5):645-51. PubMed ID: 21222012
    [Abstract] [Full Text] [Related]

  • 14. Detection of Hantaan virus RNA from anti-Hantaan virus IgG seronegative rodents in an area of high endemicity in Republic of Korea.
    No JS, Kim WK, Kim JA, Lee SH, Lee SY, Kim JH, Kho JH, Lee D, Song DH, Gu SH, Jeong ST, Kim HC, Klein TA, Song JW.
    Microbiol Immunol; 2016 Apr 13; 60(4):268-71. PubMed ID: 26917012
    [Abstract] [Full Text] [Related]

  • 15. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
    Liang M, Mahler M, Koch J, Ji Y, Li D, Schmaljohn C, Bautz EK.
    J Med Virol; 2003 Jan 13; 69(1):99-107. PubMed ID: 12436484
    [Abstract] [Full Text] [Related]

  • 16. Cellular immune response to Hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity.
    Wang M, Wang J, Zhu Y, Xu Z, Yang K, Yang A, Jin B.
    J Infect Dis; 2009 Jan 15; 199(2):188-95. PubMed ID: 19072554
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8+ T cells.
    Ma Y, Tang K, Zhang Y, Zhang C, Zhang Y, Jin B, Ma Y.
    Virol J; 2020 Jan 31; 17(1):15. PubMed ID: 32005266
    [Abstract] [Full Text] [Related]

  • 18. DNA vaccines for HFRS: laboratory and clinical studies.
    Schmaljohn CS, Spik KW, Hooper JW.
    Virus Res; 2014 Jul 17; 187():91-6. PubMed ID: 24370868
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Hantaan and Seoul viral infections among patients with hemorrhagic fever with renal syndrome (HFRS) in Heilongjiang, China.
    Zhang X, Chen HY, Zhu LY, Zeng LL, Wang F, Li QG, Shao FJ, Jiang HQ, Liu SJ, Ma YJ, Zhu Y, Ma YJ.
    Scand J Infect Dis; 2011 Aug 17; 43(8):632-41. PubMed ID: 21428852
    [Abstract] [Full Text] [Related]

  • 20. Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7.
    Li K, Li PY, Wu XA, Zhang L, Liu ZY, Yu L, Zhang L, Cheng LF, Bai WT, Zhang FL, Xu ZK.
    Int J Mol Med; 2013 Sep 17; 32(3):709-16. PubMed ID: 23783439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.